Detection and disposition of tolmetin in the horse

Journal of Pharmaceutical and Biomedical Analysis

Volumn 31, Issue 4, 2003, Pages 723-730

  Van Eenoo, P ^a   Delbeke, F T ^a   Roels, K ^a   Baert, K ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Doping control; Horse; Pharmacokinetics; Tolmetin

Indexed keywords

DRUG METABOLITE; ION; NONSTEROID ANTIINFLAMMATORY AGENT; PLASMA PROTEIN; TOLMETIN;

ANIMAL EXPERIMENT; ARTICLE; BREEDING; DIET RESTRICTION; DOPING; DRUG BLOOD LEVEL; DRUG CONJUGATION; DRUG DETERMINATION; DRUG DISPOSITION; DRUG EXCRETION; DRUG HALF LIFE; DRUG HYDROLYSIS; DRUG PROTEIN BINDING; DRUG URINE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR PROBE; NONHUMAN; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

EID: 0037467201     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(02)00687-8     Document Type: Article

References (22)

1. Grave K., Bangen M., Engelstadt M., Soli N.E. J. Vet. Pharmacol. Ther. 15:1992;45-52.
2. Delbeke F.T., Debackere M., Vynckier L. J. Vet. Pharmacol. Ther. 14:1990;145-149.
3. Delbeke F.T., Debackere M. J. Pharm. Biomed. Anal. 10:1992;651-656.
4. Delbeke F.T., Landuyt J., Debackere M. J. Vet. Pharmacol. Ther. 17:1994;353-358.
5. Delbeke F.T., Landuyt J., Debackere M. J. Pharm. Biomed. Anal. 13:1995;1041-1047.
6. Delbeke F.T. Biomed. Chromatogr. 10:1996;172-178.
7. Delbeke F.T., Baert K., De Backer P. J. Chromatogr. B. 704:1997;207-214.
8. F.T. Delbeke, P. Van Eenoo, K. Baert, P. De Backer, in: B. Laviolette, M.R. Koupai-Abyazani (Eds.), Proceedings of the 12th International Conference of Racing Analysts and Veterinarians, 1998, pp. 256-259.
9. Stanley S., Owens N.A., Rodgers J.P. J. Chromatogr. B. 667:1995;95-103.
10. International Agreement on Breeding and Racing And Appendixes, International Federation of Horse Racing Authorities, 2002. http://www.horseracingintfed.com/ .
11. International Laboratory Accreditation Cooperation, Accreditation requirements and operating criteria for horse racing laboratories, ILAC-G7, 1996. http://www.ilac.org/ .
12. Gibaldi M., Perrier D. Swarbrick J. Pharmacokinetics. 1975;Marcel Dekker, New York.
13. Verwaal W., van Bavel M., Boot A., Bravenboer J., de Goei F., Maas C., van der Putten A. De Ware(n) Chemicus. 26:1996;1-106.
14. Bressolle F., Bromet-Petit M., Audran M. J. Chromatogr. B. 686:1996;3-10.
15. Cressman W., Wortham G.F., Plostnieks J. Clin. Pharm. Ther. 19:1976;224-233.
16. Pritchard J., Desiraju R. J. Pharm. Sci. 71:1982;964-965.
17. Colombo B., Carraba M., Sarchi C. Boll. Chim. Farm. 118:1979;176-182.
18. Selley M.L., Glass J., Triggs E.J., Thomas J. Clin. Pharm. Ther. 17:1975;599-605.
19. Hyneck M., Smith P., Munafo A., McDonagh A., Benet L. Clin. Pharmacol. Ther. 44:1988;107-114.
20. Munafo A., Hyneck M., Benet L. Pharmacology. 47:1993;309-317.
21. The Association of Official Racing Chemists, Minimum performance criteria for chromatography and mass spectrometry, AORC, personal communication.
22. International Olympic Committee, Analytical criteria for reporting low concentrations of anabolic steroids, Internal communication, IOC, Lausanne, Switzerland, 1998.